AI assistant
Sending…
Lexaria Bioscience Corp. — Director's Dealing 2014
Nov 3, 2014
34983_dirs_2014-11-03_5be4d306-5193-4790-8db2-223cf9ee0294.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LEXARIA CORP. (LXRP)
CIK: 0001348362
Period of Report: 2011-07-08
Reporting Person: Baxter Nicholas W (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-03-21 | Common Shares | P | 24000 | $0.12 | Acquired | 24000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-07-08 | Options | $0.35 | P | 150000 | Acquired | 2016-07-08 | Common Shares (150000) | Direct |
| 2014-03-21 | Warrants | $0.25 | P | 24000 | Acquired | 2015-09-21 | Common Shares (24000) | Direct |
More from Lexaria Bioscience Corp.
Interim / Quarterly Report
2026
Apr 13
Director's Dealing
2026
Mar 18
Delisting Announcement
2026
Feb 6
Regulatory Filings
2026
Jan 28
Declaration of Voting Results & Voting Rights Announcements
2026
Jan 28
Capital/Financing Update
2026
Jan 14
Delisting Announcement
2026
Jan 14
Interim / Quarterly Report
2026
Jan 13
Capital/Financing Update
2025
Dec 29
Regulatory Filings
2025
Dec 19